Invasive Ductal Carcinoma, Breast

2

Review clinical trials related to Invasive Ductal Carcinoma, Breast. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer

The purpose of this study is to determine if the dose of radiation therapy that is effective in producing a treatment response, delivered over a shorter treatment period, is a safe approach that causes few or mild side effects in women with newly diagnosed breast cancer or DCIS who have had a lumpectomy procedure.

Participants needed: 280
Trial details
Phase: Phase 2Age: 45+Biological sex: FemaleType: InterventionalSponsor: Memorial Sloan Kettering Cancer CenterUpdated: Sep 16, 2025Locations: 9
Eligibility criteria

Female [+14]

Patients with distant metastasis [+13]

Status: Recruiting

Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer

This is a prospective, multicenter, randomized, parallel controlled, open-label study. The primary purpose of this study is to evaluate the efficacy of Huaier Granule on postoperative adjuvant therapy of high-risk early-stage triple-negative invasive ductal carcinoma. The Secondary purposes are to evaluate the safety of long-term use of Huaier granules as postoperative adjuvant treatment of high-risk early-stage triple-negative invasive ductal carcinoma, and the changes of quality of life score after treatment with Huaier granule.

Participants needed: 1,072
Trial details
Phase: Phase 4Age: 18-70Biological sex: AllType: InterventionalSponsor: Fudan UniversityUpdated: Jun 27, 2024Locations: 34
Eligibility criteria

Aged from 18 to 70. [+9]

Bilateral breast cancer. [+6]